Regarding the pharmacogenomics of the ABCC4 gene, the association of certain variants with 6-mercaptopurine intolerance has been described in Chinese children with ALL, while an association with hematologic toxicity was found in an Egyptian population with ALL (35, 36). Here, ABCC4 is linked to acute lymphoblastic leukemia.